Sanofi (SNY) Current Assets (2009 - 2026)

Sanofi (SNY) has 18 years of Current Assets data on file, last reported at $35.3 billion in Q1 2026.

• Quarterly Current Assets fell 23.73% year-over-year to $35.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.3 billion (down 23.73% YoY) and the FY2025 annual result came in at $36.0 billion, down 20.83% from the prior year.
• Current Assets slipped to $35.3 billion in Q1 2026 per SNY's latest filing, from $36.0 billion in the prior quarter.
• The five-year high for Current Assets was $46.3 billion in Q1 2025, with the low at $30.3 billion in Q2 2022.
• Average Current Assets over 5 years is $37.1 billion, with a median of $35.3 billion recorded in 2026.
• Year-over-year, Current Assets soared 37.91% in 2024 and slipped 23.73% in 2026.
• Sanofi's Current Assets stood at $34.8 billion in 2022, then dropped by 5.18% to $33.0 billion in 2023, then jumped by 37.91% to $45.5 billion in 2024, then retreated by 20.83% to $36.0 billion in 2025, then decreased by 1.98% to $35.3 billion in 2026.
• Business Quant data shows SNY's Current Assets at $35.3 billion in Q1 2026, $36.0 billion in Q4 2025, and $39.8 billion in Q3 2025.